IRMD

Q: What is the price of iRadimed (IRMD) today?

The current price of iRadimed (IRMD) is $ 93.71, representing a 83.69% gain over the past year. The stock began the year trading around $ 97.28 and is currently priced at $ 93.71. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does iRadimed (IRMD) pay dividends?

In the last year, iRadimed (IRMD) distributed dividends in the month of March, totaling $ 0.20. The Dividend Yield for the last 12 months is 1.29%.

Q: Is iRadimed (IRMD) a good investment?

iRadimed (IRMD) is currently trading at $ 93.71 with a P/E ratio of 54.19%. This represents a 3,794% premium compared to its historical average P/E. Over the past year, the stock has gained 83.69 and paid $ 0.20 in dividends, resulting in a dividend yield of 1.29%. The total shareholder return over the same period was 83.69%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

iRadimed Corporation

Price

$ 93.71

return (12m)

83.69%

p/e

54.19

p/bv

12.87

DIVIDEND YIELD

1.29%

IRMD price

IRMD

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment IRMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-5.82%

3 months

-7.95%

1 year

83.69%

2 years

134.92%

5 years

294.59%

10 years

528.41%

Fundamentals IRMD

review the fundamentals of iRadimed shares

P/E

54.19

Sector: -2.29 Industry: 10.92

P/S (PSR)

14.54

Sector: 1.99 Industry: 1.60

P/BV

12.87

Sector: 2.18 Industry: 3.07

DIVIDEND YIELD (DY)

1.29%

Sector: - Industry: 0.01%

ROA

20.67%

Sector: -26.05% Industry: 2.70%

ROE

23.76%

Sector: -29.81% Industry: 5.25%

ROIC

42.03%

Sector: -416.93% Industry: -2.27%

NET MARGIN

26.82%

Sector: -28.23% Industry: 2.71%

GROSS MARGIN

76.75%

Sector: 44.66% Industry: 28.76%

OPERATING MARGIN

31.19%

Sector: -23.34% Industry: 1.39%

EV/EBITDA

45.22

Sector: -0.62 Industry: 4.03

EV/EBIT

46.60

Sector: -1.80 Industry: 2.44

PRICE-TO-ASSETS

11.20

Sector: 1.17 Industry: 1.44

BVPS

7.28

Sector: 3.79 Industry: 11.41

EPS

1.73

Sector: -0.90 Industry: 1.09

EQUITY-TO-ASSETS RATIO

0.87

Sector: 0.43 Industry: 0.46

LIABILITIES / ASSETS

0.13

Sector: 0.46 Industry: 0.52

CAGR REVENUE 5 YEARS

14.92%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

19.24%

Sector: - Industry: -

FAIR VALUE OF iRadimed ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 93.71

Fair Value

$ 0.00

Upside/Downside Return potential.

-82.04%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals IRMD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.20	34.79	86.53%	0.67%	$ 829.69 B	31.66%
ISRG	58.32	9.28	15.92%	0.00%	$ 166.57 B	28.38%
TMO	29.53	3.70	12.52%	0.33%	$ 198.00 B	15.05%
SNY	12.86	1.40	10.86%	4.60%	$ 117.31 B	18.68%
NVS	20.81	6.25	30.04%	4.59%	$ 291.02 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	23.97	2.25	9.38%	3.30%	$ 110.58 B	13.00%
GSK	15.37	5.49	35.71%	3.00%	$ 117.24 B	17.48%
CVS	55.53	1.30	2.35%	3.44%	$ 98.17 B	0.44%
BSX	32.87	0.00	0.00%	0.00%	$ 95.25 B	14.44%
TMDX	20.70	8.33	40.22%	0.00%	$ 3.94 B	31.43%
HCA	16.40	-40.15	-244.82%	0.60%	$ 111.26 B	8.97%
IDXX	44.49	29.36	65.99%	0.00%	$ 47.14 B	24.62%
RMD	22.41	5.27	23.51%	1.02%	$ 33.31 B	27.53%
DHR	38.10	2.62	6.88%	0.66%	$ 137.69 B	14.71%
INMD	9.84	1.35	13.73%	0.00%	$ 922.95 M	25.32%
PHG	27.23	2.20	8.06%	2.98%	$ 28.25 B	5.07%
FMS	11.87	0.80	6.75%	3.36%	$ 13.40 B	5.02%
SYK	40.51	5.86	14.48%	0.99%	$ 131.49 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

IRMD Historical Dividends

current DY: 1.29%

5-year average DY: 2.11%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/23/2026	03/06/2026	0,20000000
Dividends	12/17/2025	12/30/2025	0,50000000
Dividends	11/14/2025	11/25/2025	0,17000000
Dividends	08/18/2025	08/28/2025	0,17000000
Dividends	05/20/2025	05/30/2025	0,17000000
Dividends	02/24/2025	03/05/2025	0,17000000
Dividends	11/15/2024	11/25/2024	0,15000000
Dividends	08/20/2024	08/30/2024	0,15000000
Dividends	05/20/2024	05/30/2024	0,15000000
Dividends	12/22/2023	01/12/2024	0,15000000
Dividends	02/13/2023	02/21/2023	1,05000000
Dividends	02/17/2022	02/24/2022	1,00000000

ABOUT iRadimed

iRadimed Corporation

Average Investor10 user rating

4.0 (5 people)

United States

34 years

Founded: 1992

2014

Time since IPO - 12 years

110

Employees

iRadimed Corporation (United States) is listed on the Nasdaq and has a market capitalization of $1.22 Billion, with shareholders equity totaling $94.62 Millions.

The company employs approximately 110 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, iRadimed Corporation reported $83.81 Millions in revenue, generating net income of $22.48 Millions.

Key financial metrics include a P/E ratio of 54.19, a price-to-book (P/B) ratio of 12.87, and a trailing twelve-month dividend yield of 1.29%.

The company trades under the ticker IRMD.

Market cap

$ 1.22 Billion

Net worth

$ 94.62 Millions

$ 94,620,000.00

Assets

$ 108.78 Millions

$ 108,780,000.00

Total Shares Outstanding

13.00 Millions

13,000,000

Average Daily Trading Volume

$ 81.10 Thousand

$ 81,103.68

Sector

Health

Industry

Medical Supplies and Equipment

IRMD

IRMD revenue and profits

Financial Results IRMD

DRAG THE FRAME TO SEE MORE DATA

IRMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.30 20,29% (12M)

P/E

55.53

3.44%

ROE

2.35%

P/BV

1.30

CI - Cigna

$ 278.64 --13,81% (12M)

P/E

10.79

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 38.17 --37,12% (12M)

P/E

-2.81

0.00%

ROE

-33.28%

P/BV

0.94

HUM - Humana

$ 205.14 --20,95% (12M)

P/E

20.72

1.73%

ROE

6.70%

P/BV

1.39

HCA - HCA Healthcare

$ 488.00 46,66% (12M)

P/E

16.40

0.60%

ROE

-244.82%

P/BV

-40.15

LLY - Eli Lilly

$ 927.03 14,15% (12M)

P/E

40.20

0.67%

ROE

86.53%

P/BV

34.79

NVS - Novartis

$ 151.97 44,80% (12M)

P/E

20.81

4.59%

ROE

30.04%

P/BV

6.25